Oklahoma SB34 creates the Access to Lifesaving Medicines Act, prohibiting excess cost burdens on insureds and requiring rebates for certain health.
Oklahoma SB34, known as the Access to Lifesaving Medicines Act, aims to protect insureds from excessive costs at the point of sale for prescription drugs. It prohibits health insurers and pharmacy benefits managers from imposing costs on insureds that exceed the net cost after applying a pro rata portion of any claim. The act also mandates that pharmacy benefits managers offer rebates to certain health benefit plans. The act will become effective November 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.